Physical factors in the rehabilitative treatment of patients with benign prostatic hyperplasia
Karpukhin, I.V.; Li, A.A.; Bogomol'nyĭ, V.A.
Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 48-52
1999
ISSN/ISBN: 0042-8787 PMID: 10641556 Document Number: 503100
Document emailed within 1 workday
Related Documents
Yu, G.I.; Hao, J.R. 1996: Postoperative nursing of patients with benign prostatic hyperplasia following treatment with net-stents Zhonghua Hu Li Za Zhi 31(11): 642-644Magoha, G.A. 1998: Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia East African Medical Journal 75(5): 260-263
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Kupriyanov, Y.A.; Rasner, P.I.; Rokhlikov, I.M.; Akrikidi, A.A.; Soloviev, V.V.; Markov, A.A.; Nozdrin, E.V.; Logvinov, L.A.; Vasilevskiy, R.P.; Skrupskiy, K.S.; Pushkar, D.Y.; Putilovskiy, M.A.; Epstein, O.I. 2019: The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia Urologiia 3: 36-42
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Sorokina, E.I. 1983: Use of physical factors in the rehabilitative treatment of myocardial infarct patients in the convalescence phase Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 1-7
Zhiborev, A.B.; Martov, A.G. 2018: The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia Urologiia 4: 81-87
Zhang, Y.-g.; Wang, J.-y.; Liu, M.; Wan, B.; Wei, D.; Deng, S.-m.; Xu, J.; Wu, J.-y.; Chu, X.; Zeng, P. 2008: Data analysis of the objective observation parameters of benign prostatic hyperplasia patients accepting different treatment regimens Zhonghua Yi Xue Za Zhi 88(24): 1690-1692
Chen, Q.; Wang, Y.-X. 2002: Correlation of the factors on benign prostatic hyperplasia combined with obstruction Zhonghua Nan Ke Xue 8(4): 299-301
Boyle, P. 1994: Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension British Journal of Clinical Practice. Suppl 74: 18-22
Pytel', I.A.; Lopatkin, N.A.; Gorilovskiĭ, L.M.; Vinarov, A.Z.; Sivkov, A.V.; Medvedev, A.A. 2004: The results of long-term permixon treatment in patients with symptoms of lower urinary tracts dysfunction due to benign prostatic hyperplasia Urologiia 2: 3-7
Suardi, N.; Gandaglia, G.; Nini, A.; Montorsi, F.; Pellucchi, F.; Agostini, A.; Rigatti, P. 2014: Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment Minerva Urologica e Nefrologica 66(2): 119-125
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Gu, R.-Z.; Xia, S.-J. 2011: Surgical options for benign prostatic hyperplasia: impact on sexual function and risk factors Zhonghua Nan Ke Xue 17(9): 837-841
Leschenko, I.G.; Bratchikov, O.I.; Shatokhina, I.V.; Akimov, A.I. 2018: The choice of individual treatment strategy in geriatric patients with benign prostatic hyperplasia with consideration of indications and contraindications for elective isolated and simultaneous interventions Urologiia 5: 46-52
Kumanov, H.; Mladenov, D.; Nikolov, S.; Penkov, R.; Stratev, S.; Kotzev, R.; Petkova, L.; Ganev, T.; Uzunov, A.; Uzunov, N. 1998: Treatment of benign prostatic hyperplasia with tamsulosin Khirurgiia 53(6): 38-41
Ekman, P.; Andersen, J.T.; Wolf, H. 1996: Finasteride in the treatment of benign prostatic hyperplasia Acta Urologica Belgica 64(1): IX-XII
McConnell, J.D. 1995: Benign prostatic hyperplasia. Hormonal treatment Urologic Clinics of North America 22(2): 387-400